Numinus Plans to Refocus on U.S. Market, Considers Divesting Canadian Operations

April 18, 2024

Cybin Receives New Patent for Psilocybin Depression Treatment

April 18, 2024

Historic Shulgin Farm Undergoing Transformation Effort

April 16, 2024

Clairvoyant Expects to Bring Psilocybin Treatment to Market By 2025

April 5, 2024

Optimi Health to Provide MDMA for Alcohol Addiction Research in Israel

March 27, 2024

Madrigal Mental Care Completes Nanotechnology Research on Ketamine

March 13, 2024